{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:38:26Z","timestamp":1778657906344,"version":"3.51.4"},"reference-count":150,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["94-01-41-28875"],"award-info":[{"award-number":["94-01-41-28875"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.humimm.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T19:37:20Z","timestamp":1515526640000},"page":"178-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Epigenetics and pathogenesis of systemic sclerosis; the ins and outs"],"prefix":"10.1016","volume":"79","author":[{"given":"Saeed","family":"Aslani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheila","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Gharibdoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-8831","authenticated-orcid":false,"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.humimm.2018.01.003_b0005","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Hoogen","year":"2013","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.humimm.2018.01.003_b0010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/ijd.13308","article-title":"Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis","volume":"55","author":"Jafarinejad-Farsangi","year":"2016","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08916934.2015.1030616","article-title":"MicroRNA-29a induces apoptosis via increasing the Bax: Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis","volume":"48","author":"Jafarinejad-Farsangi","year":"2015","journal-title":"Autoimmunity"},{"issue":"suppl 3","key":"10.1016\/j.humimm.2018.01.003_b0020","first-page":"iii45","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1018847126143","article-title":"Intestinal perforation. A common complication of scleroderma","volume":"42","author":"Ebert","year":"1997","journal-title":"Digest. Dis. Sci."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"key":"10.1016\/j.humimm.2018.01.003_b0035","series-title":"Genetics of Systemic Sclerosis. Systemic Sclerosis","first-page":"81","author":"Tsuchiya","year":"2016"},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-016-3526-0","article-title":"Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis","volume":"36","author":"Mahmoudi","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2016.01.016","article-title":"Genetic factors and systemic sclerosis","volume":"15","author":"Murdaca","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2018.01.003_b0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","article-title":"Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways","volume":"64","author":"Bossini-Castillo","year":"2015","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/ard.2008.091348","article-title":"Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database","volume":"68","author":"Walker","year":"2009","journal-title":"Ann. Rheumat. Dis."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0060","first-page":"2348","article-title":"Geographical clustering of mortality from systemic sclerosis in the Southeastern United States, 1981\u201390","volume":"24","author":"Walsh","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2018.01.003_b0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biocel.2015.05.023","article-title":"Epigenetic mechanisms: an emerging role in pathogenesis and its therapeutic potential in systemic sclerosis","volume":"67","author":"Luo","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.humimm.2018.01.003_b0070","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.humimm.2018.01.003_b0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcell.2014.00049","article-title":"Epigenetics across the human lifespan","volume":"2","author":"Kanherkar","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.humimm.2018.01.003_b0080","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ajhg.2010.02.005","article-title":"Genetic control of individual differences in gene-specific methylation in human brain","volume":"86","author":"Zhang","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrg3000","article-title":"Epigenome-wide association studies for common human diseases","volume":"12","author":"Rakyan","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0095","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/ijms17030356","article-title":"Crosstalk between long noncoding RNAs and MicroRNAs in health and disease","volume":"17","author":"Bayoumi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13059-016-1046-5","article-title":"The epigenome: the next substrate for engineering","volume":"17","author":"Park","year":"2016","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/14397595.2016.1206174","article-title":"New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications","volume":"27","author":"Mahmoudi","year":"2017","journal-title":"Modern Rheumatol."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2011.10.022","article-title":"Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?","volume":"11","author":"Costenbader","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/08916934.2015.1134511","article-title":"Epigenetic alterations underlying autoimmune diseases","volume":"49","author":"Aslani","year":"2016","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.humimm.2018.01.003_b0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"ImmunoTargets Ther."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00403-013-1410-1","article-title":"The role of microRNAs in skin fibrosis","volume":"305","author":"Babalola","year":"2013","journal-title":"Arch. Dermatol. Res."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2018.01.003_b0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11010-015-2408-0","article-title":"c-Abl silencing reduced the inhibitory effects of TGF-\u03b21 on apoptosis in systemic sclerosis dermal fibroblasts","volume":"405","author":"Karimizadeh","year":"2015","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00403-014-1532-0","article-title":"Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts","volume":"307","author":"Karimizadeh","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.humimm.2018.01.003_b0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13223-016-0158-5","article-title":"Genetic and epigenetic studies of atopic dermatitis","volume":"12","author":"Bin","year":"2016","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0150","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15027752","article-title":"CpG island evolution in the mammalian DHRS4 gene cluster and its role in the regulation of gene transcription","volume":"15","author":"Su","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"10","key":"10.1016\/j.humimm.2018.01.003_b0155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molcel.2008.12.016","article-title":"ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation","volume":"33","author":"Hung","year":"2009","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.celrep.2016.08.083","article-title":"Reversible regulation of promoter and enhancer histone landscape by DNA methylation in mouse embryonic stem cells","volume":"17","author":"King","year":"2016","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.humimm.2018.01.003_b0170","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","article-title":"Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway","volume":"276","author":"Czuwara-Ladykowska","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.humimm.2018.01.003_b0175","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"46","key":"10.1016\/j.humimm.2018.01.003_b0180","doi-asserted-by":"crossref","first-page":"33002","DOI":"10.1074\/jbc.274.46.33002","article-title":"Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation","volume":"274","author":"Pradhan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2018.01.003_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/labmed\/lmw040","article-title":"Association of DNA methyltransferase 3B promotor polymorphism with childhood chronic immune thrombocytopenia","author":"Gouda","year":"2016","journal-title":"Lab. Med."},{"issue":"11","key":"10.1016\/j.humimm.2018.01.003_b0190","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s10067-016-3403-x","article-title":"Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis","volume":"35","author":"Aslani","year":"2016","journal-title":"Clin. Rheumat."},{"issue":"10","key":"10.1016\/j.humimm.2018.01.003_b0195","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/jid.2010.162","article-title":"Epigenetically altered wound healing in keloid fibroblasts","volume":"130","author":"Russell","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nm.2135","article-title":"Methylation determines fibroblast activation and fibrogenesis in the kidney","volume":"16","author":"Bechtel","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2018.01.003_b0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2014.06.006","article-title":"DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1\/2","volume":"323","author":"Tao","year":"2014","journal-title":"Toxicology"},{"issue":"6765","key":"10.1016\/j.humimm.2018.01.003_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2018.01.003_b0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2016.06.020","article-title":"The critical role of epigenetics in systemic lupus erythematosus and autoimmunity","volume":"74","author":"Long","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2018.01.003_b0220","first-page":"4065382","article-title":"Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy","volume":"2016","author":"Li","year":"2016","journal-title":"J. Diab. Res."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0225","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1139\/o02-080","article-title":"Dynamics of histone acetylation in vivo. A function for acetylation turnover?","volume":"80","author":"Waterborg","year":"2002","journal-title":"Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.humimm.2018.01.003_b0230","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/S0021-9258(18)62212-4","article-title":"Sites of in vivo acetylation in trout testis histone IV","volume":"246","author":"Candido","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0235","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0021-9258(17)36054-4","article-title":"Nonrandom utilization of acetylation sites in histones isolated from Tetrahymena. Evidence for functionally distinct H4 acetylation sites","volume":"261","author":"Chicoine","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2018.01.003_b0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.rbr.2014.09.007","article-title":"Costa IPd. Autoanticorpos em esclerose sist\u00eamica e sua correla\u00e7\u00e3o com as manifesta\u00e7\u00f5es cl\u00ednicas da doen\u00e7a em pacientes do Centro-Oeste do Brasil","volume":"55","author":"Coelho Horimoto","year":"2015","journal-title":"Revista Brasileira de Reumatologia."},{"issue":"341","key":"10.1016\/j.humimm.2018.01.003_b0245","doi-asserted-by":"crossref","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","article-title":"Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis","volume":"7","author":"Svegliati","year":"2014","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0250","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/annrheumdis-2012-201615","article-title":"Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis","volume":"72","author":"Kramer","year":"2013","journal-title":"Ann. Rheumat. Dis."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.humimm.2018.01.003_b0260","first-page":"A26","article-title":"Promoter hypermethylation of the anti-fibrotic gene socs-3 by TGF\u03b2 as novel mechanism in the pathogenesis of SSc","volume":"69","author":"Dees","year":"2010","journal-title":"Ann. Rheumat. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0265","first-page":"189","article-title":"MicroRNAs: biogenesis, function and applications","volume":"11","author":"Chua","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"23","key":"10.1016\/j.humimm.2018.01.003_b0270","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1242\/dev.025080","article-title":"miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex","volume":"135","author":"De Pietri","year":"2008","journal-title":"Development (Cambridge, England)"},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3899\/jrheum.140502","article-title":"The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus","volume":"42","author":"Steen","year":"2015","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0280","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.yexcr.2011.05.001","article-title":"Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation","volume":"317","author":"Chen","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0285","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/08916934.2015.1072518","article-title":"MicroRNA-150: a potential regulator in pathogens infection and autoimmune diseases","volume":"48","author":"Huang","year":"2015","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0290","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.kint.2016.01.029","article-title":"Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation","volume":"89","author":"Bijkerk","year":"2016","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0295","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00705-015-2474-3","article-title":"Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7","volume":"160","author":"Zhu","year":"2015","journal-title":"Arch. Virol."},{"issue":"11","key":"10.1016\/j.humimm.2018.01.003_b0300","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/gt.2015.56","article-title":"miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells","volume":"22","author":"Kumar","year":"2015","journal-title":"Gene Ther."},{"issue":"17","key":"10.1016\/j.humimm.2018.01.003_b0305","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.2174\/1381612820666141226095701","article-title":"MicroRNA-21: a central regulator of fibrotic diseases via various targets","volume":"21","author":"Huang","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0310","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and function of miRNA-21 in health and disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.humimm.2018.01.003_b0315","doi-asserted-by":"crossref","first-page":"8319283","DOI":"10.1155\/2016\/8319283","article-title":"TGF-\u03b21\/Smads and miR-21 in Renal Fibrosis and Inflammation","volume":"2016","author":"Loboda","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0320","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/exd.12673","article-title":"O'reilly S. Current frontiers in systemic sclerosis pathogenesis","volume":"24","author":"Ciechomska","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0325","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0335","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0340","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/jid.2012.479","article-title":"p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-\u03b2: epigenetic feed-forward amplification of fibrosis","volume":"133","author":"Ghosh","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.humimm.2018.01.003_b0345","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","article-title":"Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts","volume":"48","author":"Mori","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGFbeta-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0355","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajpath.2012.09.023","article-title":"miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin \u03b23","volume":"182","author":"Honda","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0360","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","article-title":"miR-29 is a major regulator of genes associated with pulmonary fibrosis","volume":"45","author":"Cushing","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2230.2011.04158.x","article-title":"Circulating miR-142-3p levels in patients with systemic sclerosis","volume":"37","author":"Makino","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0370","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2353\/ajpath.2006.041306","article-title":"Increased expression of integrin \u03b1v\u03b25 induces the myofibroblastic differentiation of dermal fibroblasts","volume":"168","author":"Asano","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0375","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.21246","article-title":"Involvement of \u03b1V\u03b25 integrin\u2013mediated activation of latent transforming growth factor \u03b21 in autocrine transforming growth factor \u03b2 signaling in systemic sclerosis fibroblasts","volume":"52","author":"Asano","year":"2005","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0380","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0385","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14728222.2012.708339","article-title":"MicroRNA-29: a potential therapeutic target for systemic sclerosis","volume":"16","author":"Peng","year":"2012","journal-title":"Expert Opin. Therap. Targets"},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0390","doi-asserted-by":"crossref","first-page":"e115596","DOI":"10.1371\/journal.pone.0115596","article-title":"MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-\u03b2 activated kinase 1 binding protein 1, implications for systemic sclerosis","volume":"9","author":"Ciechomska","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0395","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0400","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/mt.2012.36","article-title":"miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice","volume":"20","author":"Xiao","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.humimm.2018.01.003_b0405","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biocel.2014.06.011","article-title":"miR-92a regulates TGF-beta1-induced WISP1 expression in pulmonary fibrosis","volume":"53","author":"Berschneider","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.humimm.2018.01.003_b0410","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.1100876","article-title":"TGF-\u03b2\u2013mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts","volume":"188","author":"Honda","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0415","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1684\/ejd.2014.2384","article-title":"Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients","volume":"24","author":"Makino","year":"2014","journal-title":"Eur. J. Dermatol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0420","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/jid.2012.22","article-title":"miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts","volume":"132","author":"Kashiyama","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0425","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0430","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0435","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10875-011-9647-y","article-title":"MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma","volume":"32","author":"Zhu","year":"2012","journal-title":"J. Clin. Immunol.."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0440","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s10875-013-9896-z","article-title":"MicroRNA-21 in scleroderma fibrosis and its function in TGF-\u03b2-regulated fibrosis-related genes expression","volume":"33","author":"Zhu","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0445","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1165\/rcmb.2015-0205OC","article-title":"MicroRNA-27a-3p Is a negative regulator of lung fibrosis by targeting myofibroblast differentiation","volume":"54","author":"Cui","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0450","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/jcb.24809","article-title":"MicroRNA-27b targets gremlin 1 to modulate fibrotic responses in pulmonary cells","volume":"115","author":"Graham","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"1 Supplement","key":"10.1016\/j.humimm.2018.01.003_b0455","article-title":"Functional analysis of FOXC1 in TGF-\u03b2 mediated epithelial to mesenchymal transition","volume":"29","author":"Berry","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0460","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017453","article-title":"miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression","volume":"15","author":"Wang","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0465","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/1751-2980.12266","article-title":"miR-30c and miR-193 are a part of the TGF-beta-dependent regulatory network controlling extracellular matrix genes in liver fibrosis","volume":"16","author":"Roy","year":"2015","journal-title":"J. Digest. Dis."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0470","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2011-08-372383","article-title":"Liu Z-g. Induction of autophagy is essential for monocyte-macrophage differentiation","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0475","doi-asserted-by":"crossref","first-page":"F369","DOI":"10.1152\/ajprenal.00268.2011","article-title":"The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression","volume":"302","author":"Xiong","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0480","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.11-186098","article-title":"Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-\u03b2 production and epithelial to mesenchymal transition","volume":"26","author":"Schneider","year":"2012","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0485","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.3892\/mmr.2015.4374","article-title":"MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFbeta signaling pathway","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0490","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2018.01.003_b0495","article-title":"Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients","author":"Zununi Vahed","year":"2016","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0500","first-page":"615","article-title":"Altered expression of MicroRNAs following chronic allograft dysfunction with interstitial fibrosis and tubular atrophy","volume":"14","author":"Soltaninejad","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11926-006-0052-0","article-title":"T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities","volume":"8","author":"Del Galdo","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-1-200401060-00010","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.humimm.2018.01.003_b0515","article-title":"Epigenetic variability of CD4+CD25+ Tregs contributes to the pathogenesis of autoimmune diseases","author":"Shu","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0520","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.1400599","article-title":"Hypomethylation at the regulatory T cell-specific demethylated region in CD25(hi) T cells Is decoupled from FOXP3 expression at the inflamed site in childhood arthritis","volume":"193","author":"Bending","year":"2014","journal-title":"J. Immunol. Author Choice"},{"key":"10.1016\/j.humimm.2018.01.003_b0525","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1476-4598-13-153","article-title":"Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival","volume":"13","author":"Zhuo","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0530","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/08830185.2013.811657","article-title":"The role of FOXP3 in regulating immune responses","volume":"33","author":"Vent-Schmidt","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0535","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/08820139.2014.938165","article-title":"Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections","volume":"44","author":"Ngalamika","year":"2015","journal-title":"Immunol. Invest."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0540","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0545","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-009-0071-8","article-title":"Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease","volume":"12","author":"Veraldi","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0550","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann. Rheumat. Dis."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0555","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1468-3083.2012.04558.x","article-title":"Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis","volume":"27","author":"Taniguchi","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0560","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-065X.2009.00771.x","article-title":"Costimulatory and coinhibitory receptors in anti-tumor immunity","volume":"229","author":"Driessens","year":"2009","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.humimm.2018.01.003_b0565","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.34376","article-title":"DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility","volume":"64","author":"Lian","year":"2012","journal-title":"Arthritis Rheumat."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0570","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1868-7083-6-25","article-title":"Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis","volume":"6","author":"Wang","year":"2014","journal-title":"Clin. Epigenet."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(00)80469-0","article-title":"Massive expansion of antigen-specific CD8+ T cells during an acute virus infection","volume":"8","author":"Butz","year":"1998","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0580","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri3173","article-title":"Araki Y, Subedi K. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation","volume":"12","author":"N-p","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2018.01.003_b0585","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1371\/journal.pone.0001020","article-title":"miRNA profiling of naive, effector and memory CD8 T cells","volume":"2","author":"Wu","year":"2007","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.humimm.2018.01.003_b0590","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.4049\/jimmunol.177.11.8095","article-title":"Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4","volume":"177","author":"Hilliard","year":"2006","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0595","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni.1828","article-title":"Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21","volume":"11","author":"Sheedy","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-014-0474-z","article-title":"Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis","volume":"17","author":"Bhattacharyya","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0605","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0610","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11926-004-0060-x","article-title":"Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion\/deletion polymorphism","volume":"6","author":"Fatini","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0615","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI106565","article-title":"Skin capillary blood flow in scleroderma","volume":"50","author":"LeRoy","year":"1971","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0620","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","article-title":"Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection","volume":"28","author":"Cool","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.humimm.2018.01.003_b0625","first-page":"105","article-title":"Vascular involvement in systemic sclerosis (scleroderma)","volume":"4","author":"Pattanaik","year":"2011","journal-title":"J. Inflamm. Res."},{"issue":"Pt 1","key":"10.1016\/j.humimm.2018.01.003_b0630","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.msec.2016.09.074","article-title":"Strategies for delivering bone morphogenetic protein for bone healing","volume":"70","author":"Begam","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0635","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gendis.2014.07.005","article-title":"Bone Morphogenetic Protein (BMP) signaling in development and human diseases","volume":"1","author":"Wang","year":"2014","journal-title":"Genes Dis."},{"issue":"18","key":"10.1016\/j.humimm.2018.01.003_b0640","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/sj.onc.1209297","article-title":"Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas","volume":"25","author":"Wen","year":"2006","journal-title":"Oncogene"},{"issue":"18","key":"10.1016\/j.humimm.2018.01.003_b0645","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/sj.onc.1209297","article-title":"Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas","volume":"25","author":"Wen","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0650","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#","article-title":"N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2","volume":"183","author":"Hay","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0655","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circul. Res."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0660","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann. Rheumat. Dis."},{"key":"10.1016\/j.humimm.2018.01.003_b0665","first-page":"111","article-title":"CpG sites associated with NRP1, NRXN2 and miR-29b-2 are hypomethylated in monocytes during ageing","author":"Tserel","year":"2014","journal-title":"Immun. Ageing"},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.68.1.1","article-title":"CXC chemokines in angiogenesis","volume":"68","author":"Belperio","year":"2000","journal-title":"J. Leukocyte Biol."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0675","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.humimm.2018.01.003_b0680","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0198-8859(86)90304-6","article-title":"Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells","volume":"17","author":"Richardson","year":"1986","journal-title":"Human Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2018.01.003_b0685","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1172\/JCI116924","article-title":"Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis","volume":"92","author":"Takeuchi","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0690","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1172\/JCI118743","article-title":"Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice","volume":"97","author":"Yung","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.humimm.2018.01.003_b0695","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.4049\/jimmunol.179.9.6352","article-title":"Demethylation of CD40LG on the inactive X in T cells from women with lupus","volume":"179","author":"Lu","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0700","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0705","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2012.07.006","article-title":"CD40L demethylation in CD4+ T cells from women with rheumatoid arthritis","volume":"145","author":"Liao","year":"2012","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0710","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1002\/1529-0131(200012)43:12<2634::AID-ANR3>3.0.CO;2-1","article-title":"Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression","volume":"43","author":"Neidhart","year":"2000","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.humimm.2018.01.003_b0715","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.21637","article-title":"Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells","volume":"54","author":"Takami","year":"2006","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.humimm.2018.01.003_b0720","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/art.22759","article-title":"Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis","volume":"56","author":"Huber","year":"2007","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.humimm.2018.01.003_b0725","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2006.12.204","article-title":"Trichostatin A blocks TGF-\u03b2-induced collagen gene expression in skin fibroblasts: involvement of Sp1","volume":"354","author":"Ghosh","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.humimm.2018.01.003_b0730","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.24494","article-title":"Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis","volume":"60","author":"Hemmatazad","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.humimm.2018.01.003_b0735","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCRESAHA.107.149377","article-title":"Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis","volume":"101","author":"Mottet","year":"2007","journal-title":"Circul. Res."},{"issue":"1","key":"10.1016\/j.humimm.2018.01.003_b0740","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PPO.0b013e31803c7245","article-title":"DNA methyltransferase inhibitors for cancer therapy","volume":"13","author":"Brueckner","year":"2007","journal-title":"Cancer J."},{"issue":"6990","key":"10.1016\/j.humimm.2018.01.003_b0745","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"issue":"7347","key":"10.1016\/j.humimm.2018.01.003_b0750","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature10008","article-title":"Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation","volume":"473","author":"Ficz","year":"2011","journal-title":"Nature"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T14:20:23Z","timestamp":1693405223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918300144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0198885918300144"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.01.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetics and pathogenesis of systemic sclerosis; the ins and outs","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}